TNFB polymorphism may be associated with schizophrenia in the Korean population

[1]  A. Kastrati,et al.  Interleukin-10 and tumor necrosis factor gene polymorphisms and risk of coronary artery disease and myocardial infarction. , 2001, Atherosclerosis.

[2]  C. Dion,et al.  A search for specific and common susceptibility loci for schizophrenia and bipolar disorder: a linkage study in 13 target chromosomes , 2001, Molecular Psychiatry.

[3]  K. Tabeta,et al.  Interleukin-10 gene promoter polymorphism in Japanese patients with adult and early-onset periodontitis. , 2001, Journal of clinical periodontology.

[4]  A. Madej,et al.  Neuroleptics normalize increased release of interleukin-1β and tumor necrosis factor-α from monocytes in schizophrenia , 2001, Schizophrenia Research.

[5]  Y. Kawakami,et al.  The Gene Polymorphism of Tumor Necrosis Factor-β, But Not That of Tumor Necrosis Factor-α, Is Associated With the Prognosis of Sarcoidosis , 2001 .

[6]  M. Perola,et al.  Polymorphisms within the tumor necrosis factor locus and prevalence of coronary artery disease in middle-aged men. , 2001, Atherosclerosis.

[7]  C. Stefanis,et al.  Cytokine serum levels, autologous mixed lymphocyte reaction and surface marker analysis in never medicated and chronically medicated schizophrenic patients , 2001, Schizophrenia Research.

[8]  Robin M. Murray,et al.  Schizophrenia and HLA: a review , 2001, Schizophrenia Research.

[9]  D. Housman,et al.  Genetic heterogeneity in schizophrenia: stratification of genome scan data using co-segregating related phenotypes , 2000, Molecular Psychiatry.

[10]  M. Rietschel,et al.  A genome-wide autosomal screen for schizophrenia susceptibility loci in 71 families with affected siblings: support for loci on chromosome 10p and 6 , 2000, Molecular Psychiatry.

[11]  N. Takasu,et al.  Association of CTLA-4 gene A/G polymorphism in Japanese type 1 diabetic patients with younger age of onset and autoimmune thyroid disease. , 2000, Diabetes care.

[12]  L. DeLisi,et al.  Investigation of a candidate gene for schizophrenia on Xq13 previously associated with mental retardation and hypothyroidism. , 2000, American journal of medical genetics.

[13]  T. Crow,et al.  Update on chromosomal locations for psychiatric disorders: report of the interim meeting of chromosome workshop chairpersons from the VIIth World Congress of Psychiatric Genetics, Monterey, California, October 14-18, 1999. , 2000, American journal of medical genetics.

[14]  D. Remick,et al.  Cytokines and the brain: implications for clinical psychiatry. , 2000, The American journal of psychiatry.

[15]  J. Hodges,et al.  Hashimoto's encephalopathy presenting as “myxoedematous madness” , 2000 .

[16]  Jeffrey K. Yao,et al.  Elevated interleukin-6 in schizophrenia , 1999, Psychiatry Research.

[17]  U. Pettersson,et al.  Linkage analysis of a large Swedish kindred provides further support for a susceptibility locus for schizophrenia on chromosome 6p23. , 1999, American journal of medical genetics.

[18]  W. Fiers,et al.  The role of complement activation in tumour necrosis factor-induced lethal hepatitis. , 1999, Cytokine.

[19]  J. Kennedy,et al.  Schizophrenia and the HLA-DRB1 gene in the Japanese population. , 1999, The American journal of psychiatry.

[20]  M. Hurme,et al.  Polymorphisms of the interleukin-1 gene complex in schizophrenia , 1999, Molecular Psychiatry.

[21]  R. Pioli,et al.  The inflammatory response system in treatment-resistant schizophrenia: increased serum interleukin-6 , 1998, Schizophrenia Research.

[22]  G. Salles,et al.  Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin's lymphoma outcome. , 1998, Blood.

[23]  W. Honer,et al.  Use of a quantitative trait to map a locus associated with severity of positive symptoms in familial schizophrenia to chromosome 6p. , 1997, American journal of human genetics.

[24]  J. Roth,et al.  Changes of abdominal temperature and circulating levels of cortisol and interleukin-6 in response to intra-arterial infusions of tumor necrosis factor-alpha or tumor necrosis factor-beta in guinea pigs. , 1997, European journal of pharmacology.

[25]  J. Mege,et al.  A differential role for interleukin-6 and tumor necrosis factor-α in schizophrenia? , 1997, Schizophrenia Research.

[26]  S. McQuaid,et al.  Leukaemia inhibitory factor mRNA is expressed in the brains of patients with subacute sclerosing panencephalitis , 1997, Journal of Neuroimmunology.

[27]  R. Fukuda,et al.  Genes for interleukin‐2 receptor β chain, interleukin‐1 β, and schizophrenia: No evidence for the association or linkage , 1997 .

[28]  M. Maj,et al.  Plasma levels of interleukin-6 and tumor necrosis factor alpha in chronic schizophrenia: effects of clozapine treatment , 1997, Psychiatry Research.

[29]  J. Gilmore,et al.  Exposure to infection and brain development: cytokines in the pathogenesis of schizophrenia , 1997, Schizophrenia Research.

[30]  R. Straub,et al.  Evidence for a schizophrenia vulnerability locus on chromosome 8p in the Irish Study of High-Density Schizophrenia Families. , 1996, The American journal of psychiatry.

[31]  T. Crow,et al.  Linkage analyses of schizophrenia to chromosome 6p24-p22: an attempt to replicate. , 1996, American journal of medical genetics.

[32]  J. Mege,et al.  Elevated circulating levels of IL-6 in schizophrenia , 1996, Schizophrenia Research.

[33]  F. Stüber,et al.  A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis. , 1996, Critical care medicine.

[34]  C. Cho,et al.  Systemic lupus erythematosus with nephritis is strongly associated with the TNFB*2 homozygote in the Korean population. , 1996, Human immunology.

[35]  E. Lander,et al.  Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results , 1995, Nature Genetics.

[36]  Margot Albus,et al.  Evaluation of a susceptibility gene for schizophrenia on chromosome 6p by multipoint affected sib–pair linkage analysis , 1995, Nature Genetics.

[37]  R. Straub,et al.  A potential vulnerability locus for schizophrenia on chromosome 6p24–22: evidence for genetic heterogeneity , 1995, Nature Genetics.

[38]  A. Chakravarti,et al.  Association study of schizophrenia and the IL-2 receptor β chain gene , 1995 .

[39]  B. Rabin,et al.  Mitogen-stimulated interleukin-2 production in never-medicated, first-episode schizophrenic patients. The influence of age at onset and negative symptoms. , 1995, Archives of general psychiatry.

[40]  J. Ziegle,et al.  Evidence for a susceptibility locus for schizophrenia on chromosome 6pter–p22 , 1995, Nature Genetics.

[41]  J. Calabrese,et al.  Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers. , 1995, Journal of psychiatric research.

[42]  T. Horie,et al.  Restriction fragment length polymorphism (RFLP) analysis in the TNF genes of patients with systemic lupus erythematosus (SLE). , 1993, Clinical and experimental rheumatology.

[43]  R. Murray,et al.  Schizophrenia: genetics and the maternal immune response to viral infection. , 1993, American journal of medical genetics.

[44]  M. French,et al.  Polymorphic MHC ancestral haplotypes affect the activity of tumour necrosis factor‐alpha , 1993, Clinical and experimental immunology.

[45]  W. Ewens,et al.  Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). , 1993, American journal of human genetics.

[46]  E. Albert,et al.  Polymorphism of the tumor necrosis factor beta gene in systemic lupus erythematosus: TNFB-MHC haplotypes , 1993, Immunogenetics.

[47]  J. Ragoussis,et al.  Map of the human MHC. , 1991, Immunology today.

[48]  L. DeLisi,et al.  Familial thyroid disease and delayed language development in first admission patients with schizophrenia , 1991, Psychiatry Research.

[49]  U. Spengler,et al.  Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF- beta production , 1991, The Journal of experimental medicine.

[50]  F. Pociot,et al.  Monocyte Function in IDDM Patients and Healthy Individuals , 1990, Scandinavian journal of immunology.

[51]  S. Belle,et al.  Decreased interleukin-2 production in schizophrenic patients , 1989, Biological Psychiatry.

[52]  H. Lôo,et al.  Aberrant T cell-mediated immunity in untreated schizophrenic patients: deficient interleukin-2 production. , 1989, The American journal of psychiatry.

[53]  B. Rabin,et al.  Increased serum interleukin 2 receptor concentration in schizophrenic and brain-damaged subjects. , 1989, Archives of general psychiatry.

[54]  Shirley A. Miller,et al.  A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.

[55]  R. Ganguli,et al.  Clinical and Laboratory Evidence of Autoimmunity in Acute Schizophrenia , 1987, Annals of the New York Academy of Sciences.

[56]  W. Fiers,et al.  Genes for the tumor necrosis factors alpha and beta are linked to the human major histocompatibility complex. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[57]  D. Weinberger,et al.  Abnormal cerebrospinal fluid protein indices in schizophrenia , 1985, Biological Psychiatry.

[58]  L. DeLisi,et al.  An analysis of lymphocyte subpopulations in schizophrenic patients. , 1982, Biological psychiatry.

[59]  L. DeLisi,et al.  Quantitative Determination of Immunoglobulins in CSF and Plasma of Chronic Schizophrenic Patients , 1981, British Journal of Psychiatry.

[60]  A. Farmer,et al.  HLA antigens and subtypes of schizophrenia , 1981, Psychiatry Research.

[61]  A. Farmer,et al.  Histocompatability Antigens and Schizophrenia , 1978, British Journal of Psychiatry.

[62]  S. Paul,et al.  Increased serum soluble interleukin-2 receptors in schizophrenic monozygotic twins , 2005, European Archives of Psychiatry and Clinical Neuroscience.

[63]  L. DeLisi,et al.  Deficient natural killer cell (NK) activity and macrophage functioning in schizophrenic patients , 2005, Journal of Neural Transmission.

[64]  M. Rösler,et al.  HLA antigens in schizophrenia, major depressive disorder, and schizoaffective disorder , 2005, Medical Microbiology and Immunology.

[65]  R. Pioli,et al.  Association between −G308A tumor necrosis factor alpha gene polymorphism and schizophrenia , 2001, Molecular Psychiatry.

[66]  R. Murray,et al.  Genetic association of the HLA DRB1 gene locus on chromosome 6p21.3 with schizophrenia. , 1996, The American journal of psychiatry.

[67]  I. K. Kim,et al.  Red cell enzyme and serum protein polymorphisms in South Korea. , 1989, Human heredity.